EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+15.49%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$11.9B
AUM Growth
+$4.1B
(+53%)
Cap. Flow
+$2.9B
Cap. Flow
% of AUM
24.37%
Top 10 Holdings %
Top 10 Hldgs %
28.21%
Holding
960
New
318
Increased
304
Reduced
85
Closed
35
Top Buys
| 1 |
NVIDIA
NVDA
|
$175M |
| 2 |
Microsoft
MSFT
|
$170M |
| 3 |
Apple
AAPL
|
$123M |
| 4 |
Abbott
ABT
|
$98.9M |
| 5 |
Intuit
INTU
|
$97.9M |
Top Sells
| 1 |
Arch Capital
ACGL
|
$64.1M |
| 2 |
UnitedHealth
UNH
|
$28.9M |
| 3 |
Sunrun
RUN
|
$23.8M |
| 4 |
Salesforce
CRM
|
$17.1M |
| 5 |
Nextracker
NXT
|
$11.6M |
Sector Composition
| 1 | Technology | 35.45% |
| 2 | Financials | 13.4% |
| 3 | Healthcare | 12.81% |
| 4 | Communication Services | 10.08% |
| 5 | Consumer Discretionary | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Dick's Sporting Goods
DKS
$17.7B
| $507K | ﹤0.01% |
+2,500
| New | +$507K |
|
577
Public Service Enterprise Group
PEG
$40.5B
| $499K | ﹤0.01% |
+5,971
| New | +$499K |
|
578
CorVel
CRVL
$4.39B
| $497K | ﹤0.01% |
4,800
| – | – |
|
579
Ligand Pharmaceuticals
LGND
$3.25B
| $491K | ﹤0.01% |
4,300
| – | – |
|
580
Zebra Technologies
ZBRA
$16B
| $483K | ﹤0.01% |
+1,562
| New | +$483K |
|
581
EyePoint Pharmaceuticals
EYPT
$966M
| $482K | ﹤0.01% |
50,000
| – | – |
|
582
Expeditors International
EXPD
$16.4B
| $477K | ﹤0.01% |
+4,200
| New | +$477K |
|
583
Veracyte
VCYT
$2.55B
| $465K | ﹤0.01% |
17,000
| – | – |
|
584
Tyler Technologies
TYL
$24.2B
| $465K | ﹤0.01% |
+800
| New | +$465K |
|
585
Norfolk Southern
NSC
$62.3B
| $453K | ﹤0.01% |
+1,770
| New | +$453K |
|
|
AUTL
586
Autolus Therapeutics
AUTL
$389M
| $450K | ﹤0.01% |
195,000
| – | – |
|
587
Enact Holdings
ACT
$5.69B
| $438K | ﹤0.01% |
11,900
| – | – |
|
588
Clearwater Analytics
CWAN
$6.07B
| $437K | ﹤0.01% |
+19,528
| New | +$437K |
|
589
The Mosaic Company
MOS
$10.3B
| $437K | ﹤0.01% |
+12,417
| New | +$437K |
|
590
Target
TGT
$42.3B
| $433K | ﹤0.01% |
4,255
-18,896
| -82% | -$1.92M |
|
591
Teck Resources
TECK
$16.8B
| $431K | ﹤0.01% |
+5,682
| New | +$431K |
|
592
Adaptive Biotechnologies
ADPT
$1.96B
| $421K | ﹤0.01% |
35,700
| – | – |
|
593
Kraft Heinz
KHC
$32.3B
| $420K | ﹤0.01% |
16,323
+16,048
| +5,836% | +$413K |
|
594
Harmony Biosciences
HRMY
$2.07B
| $419K | ﹤0.01% |
13,100
| – | – |
|
595
EPAM Systems
EPAM
$9.44B
| $419K | ﹤0.01% |
+2,400
| New | +$419K |
|
596
Carlisle Companies
CSL
$16.9B
| $415K | ﹤0.01% |
+1,100
| New | +$415K |
|
597
ImmunityBio
IBRX
$2.27B
| $413K | ﹤0.01% |
153,000
| – | – |
|
598
Chemours
CC
$2.34B
| $412K | ﹤0.01% |
35,142
| – | – |
|
599
Labcorp
LH
$23.2B
| $411K | ﹤0.01% |
1,600
-859
| -35% | -$221K |
|
600
Delta Air Lines
DAL
$39.9B
| $409K | ﹤0.01% |
+8,352
| New | +$409K |
|